	US 11,938,190 B2
	Herbal extracts for treatment of herpesvirus infections
Yonit Bomstein, Petach Tikwa (IL); Jonathan Marder, Rechovot (IL); and Tali Pechenick Jowers, Raanana (IL)
Assigned to KAMEDIS LTD, Tel Aviv (IL)
Appl. No. 16/959,174
Filed by KAMEDIS LTD., Tel Aviv (IL)
PCT Filed Dec. 30, 2018, PCT No. PCT/IL2018/051409 § 371(c)(1), (2) Date Jun. 30, 2020, PCT Pub. No. WO2019/135215, PCT Pub. Date Jul. 11, 2019.
Claims priority of provisional application 62/612,724, filed on Jan. 2, 2018.
Prior Publication US 2020/0397908 A1, Dec. 24, 2020
Int. Cl. A61K 47/46 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/522 (2006.01); A61K 47/10 (2017.01); A61K 47/22 (2006.01)

CPC A61K 47/46 (2013.01) [A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 31/522 (2013.01); A61K 47/10 (2013.01); A61K 47/22 (2013.01)]

12 Claims

1. A formulation consisting of extracts of Rheum palmatum, Chrysanthemum indicum and Sanguisorba officinalis and a pharmaceutically acceptable carrier in an effective amount to treat a herpesvirus infection and/or prevent diseases resulting therefrom in humans.